1 Year Absolute Returns
5.89% ↑
NAV (₹) on 17 Apr 2026
9.80
1 Day NAV Change
0.66%
Risk Level
Very High Risk
Rating
-
Bajaj Finserv Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Bajaj Finserv Asset Management Limited. Launched on 06 Dec 2024, investors can start with a ... Read more
AUM
₹ 300.45 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 64.73% |
| Hospitals & Medical Services | 18.33% |
| Net Receivables/(Payables) | 3.52% |
| Personal Care | 2.49% |
| Food Processing & Packaging | 2.46% |
| Chemicals - Others | 2.05% |
| Chemicals - Speciality | 1.98% |
| Mutual Fund Units | 1.73% |
| Plastics - Plastic & Plastic Products | 1.72% |
| Insurance Distributor | 0.99% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 9.41% | ₹ 28.26 | Pharmaceuticals |
| Divi's Laboratories Limited | 8.95% | ₹ 26.90 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.75% | ₹ 20.29 | Hospitals & Medical Services |
| Aurobindo Pharma Limited | 6.63% | ₹ 19.93 | Pharmaceuticals |
| Piramal Pharma Limited | 5.69% | ₹ 17.10 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 5.57% | ₹ 16.72 | Pharmaceuticals |
| Emcure Pharmaceuticals Limited | 4.35% | ₹ 13.08 | Pharmaceuticals |
| Max Healthcare Institute Limited | 4.06% | ₹ 12.21 | Hospitals & Medical Services |
| Rubicon Research Limited | 3.84% | ₹ 11.55 | Pharmaceuticals |
| Net Receivables / (Payables) | 3.52% | ₹ 10.50 | Others |
| Neuland Laboratories Limited | 3.42% | ₹ 10.27 | Pharmaceuticals |
| Fortis Healthcare Limited | 3.18% | ₹ 9.55 | Hospitals & Medical Services |
| IPCA Laboratories Limited | 2.69% | ₹ 8.08 | Pharmaceuticals |
| Zydus Wellness Limited | 2.46% | ₹ 7.40 | Food Processing & Packaging |
| Navin Fluorine International Limited | 2.05% | ₹ 6.16 | Chemicals - Others |
| Sanofi Consumer Healthcare India Limited | 1.98% | ₹ 5.96 | Chemicals - Speciality |
| Glenmark Pharmaceuticals Limited | 1.97% | ₹ 5.91 | Pharmaceuticals |
| GlaxoSmithKline Pharmaceuticals Limited | 1.81% | ₹ 5.43 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 1.77% | ₹ 5.32 | Hospitals & Medical Services |
| Shaily Engineering Plastics Limited | 1.72% | ₹ 5.17 | Plastics - Plastic & Plastic Products |
| Bajaj Finserv Money Market Fund-Direct Plan-Growth | 1.71% | ₹ 5.13 | Others |
| Laurus Labs Limited | 1.65% | ₹ 4.96 | Pharmaceuticals |
| Godrej Consumer Products Limited | 1.64% | ₹ 4.92 | Personal Care |
| Lupin Limited | 1.56% | ₹ 4.69 | Pharmaceuticals |
| Dr. Lal Path Labs Limited | 1.54% | ₹ 4.62 | Hospitals & Medical Services |
| Abbott India Limited | 1.50% | ₹ 4.50 | Pharmaceuticals |
| MedPlus Health Services Limited | 1.44% | ₹ 4.34 | Pharmaceuticals |
| Biocon Limited | 1.38% | ₹ 4.13 | Pharmaceuticals |
| Eris Lifesciences Limited | 1.08% | ₹ 3.24 | Pharmaceuticals |
| Krishna Institute Of Medical Sciences Limited | 1.03% | ₹ 3.11 | Hospitals & Medical Services |
| Medi Assist Healthcare Services Limited | 0.99% | ₹ 2.98 | Insurance Distributor |
| Jubilant Pharmova Limited | 0.95% | ₹ 2.86 | Pharmaceuticals |
| Emami Limited | 0.85% | ₹ 2.55 | Personal Care |
| AstraZeneca Pharma India Limited | 0.84% | ₹ 2.54 | Pharmaceuticals |
| Clearing Corporation of India Ltd | 0.02% | ₹ 0.07 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -2.65% | 5.89% | - | - |
| Category returns | -0.43% | 7.70% | 10.32% | 23.90% |
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Bajaj Finserv Large and Mid Cap Fund
Largecap
Regular
|
₹11.95 | 5.19% | 0.00% | 0.00% | ₹2,082 | 2.02% |
Very High
|
|
Bajaj Finserv Arbitrage Fund
Arbitrage
Regular
|
₹11.74 | 5.66% | 0.00% | 0.00% | ₹1,032 | 1.03% |
Low
|
|
Bajaj Finserv Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,208.48 | 6.33% | 0.00% | 0.00% | ₹3,178 | 0.08% |
Low to Moderate
|
|
Bajaj Finserv Overnight Fund
Liquid
Regular
|
₹1,032.89 | 0.00% | 0.00% | 0.00% | ₹349 | 0.13% |
Low
|
|
Bajaj Finserv Banking and PSU Fund
Income
Regular
|
₹11.80 | 4.52% | 0.00% | 0.00% | ₹323 | 0.90% |
Moderate
|
|
Bajaj Finserv Nifty 1D Rate Liquid ETF - Growth
ETF
Regular
|
₹1,077.83 | 5.03% | 0.00% | 0.00% | ₹647 | 0.19% |
Low
|
|
Bajaj Finserv Nifty Next 50 Index Fund
Index
Regular
|
₹11.11 | 0.00% | 0.00% | 0.00% | ₹25 | 0.95% |
Very High
|
|
Bajaj FinServ Multi Cap Fund - Direct Plan
Diversified
Direct
|
₹11.46 | 8.05% | 0.00% | 0.00% | ₹1,077 | 0.81% |
Very High
|
|
Bajaj Finserv Overnight Fund
Liquid
Regular
|
₹1,033.31 | -0.00% | 0.00% | 0.00% | ₹349 | 0.13% |
Low
|
|
Bajaj Finserv Overnight Fund
Liquid
Regular
|
₹1,033.57 | 0.02% | 0.00% | 0.00% | ₹349 | 0.13% |
Low
|
What is the current NAV of Bajaj Finserv Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of Bajaj Finserv Healthcare Fund - Direct Plan Growth?
What are the historical returns of Bajaj Finserv Healthcare Fund - Direct Plan Growth?
What is the risk level of Bajaj Finserv Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for Bajaj Finserv Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article